
    
      Objectives:

      General Objective:

      The aim of the study is to evaluate efficacy and safety of ivermectin in combination with
      doxycycline or ivermectin alone for the treatment of hospitalized SARS-CoV-2 infected adult
      Bangladeshi COVID-19 +ve patients and to compare with placebo; where all three arms will
      receive the standard care of treatment of COVID-19 infected patients in the hospital. By
      successful demonstration of the safety and efficacy of these repurposed medicines, it may
      have the potential to play an important role in the treatment of COVID-19+ve patients.

      Specific Objective:

        1. Duration of the virological clearance rate

        2. Days required for remission of fever and cough

      Secondary Objective:

        -  Patients requiring oxygen

        -  Patients failing to maintain SpO2 >88 despite oxygenation

        -  Number of days on oxygen support

        -  Chest X-ray improvement

        -  Duration of hospitalization

        -  All cause mortality
    
  